| Pharmaceutical cocrystallization: engineering a remedy for caffeine hydration AV Trask, WDS Motherwell, W Jones Crystal growth & design 5 (3), 1013-1021, 2005 | 806 | 2005 |
| Physical stability enhancement of theophylline via cocrystallization AV Trask, WDS Motherwell, W Jones International journal of pharmaceutics 320 (1-2), 114-123, 2006 | 673 | 2006 |
| An overview of pharmaceutical cocrystals as intellectual property AV Trask Molecular pharmaceutics 4 (3), 301-309, 2007 | 469 | 2007 |
| Pharmaceutical cocrystals: An emerging approach to physical property enhancement W Jones, WDS Motherwell, AV Trask MRS bulletin 31 (11), 875-879, 2006 | 444 | 2006 |
| Screening for inclusion compounds and systematic construction of three‐component solids by liquid‐assisted grinding T Friščić, AV Trask, W Jones, WDS Motherwell Angewandte Chemie 118 (45), 7708-7712, 2006 | 429 | 2006 |
| Crystal engineering of organic cocrystals by the solid-state grinding approach AV Trask, W Jones Organic Solid State Reactions: -/-, 41-70, 2005 | 397 | 2005 |
| Solvent-drop grinding: green polymorph control of cocrystallisation AV Trask, WDS Motherwell, W Jones Chemical Communications, 890-891, 2004 | 367 | 2004 |
| Achieving polymorphic and stoichiometric diversity in cocrystal formation: Importance of solid-state grinding, powder X-ray structure determination, and seeding AV Trask, J van de Streek, WDS Motherwell, W Jones Crystal growth & design 5 (6), 2233-2241, 2005 | 256 | 2005 |
| Solid-State Acid−Base Interactions in Complexes of Heterocyclic Bases with Dicarboxylic Acids: Crystallography, Hydrogen Bond Analysis, and 15N NMR … ZJ Li, Y Abramov, J Bordner, J Leonard, A Medek, AV Trask Journal of the American Chemical Society 128 (25), 8199-8210, 2006 | 217 | 2006 |
| Selective polymorph transformation via solvent-drop grinding AV Trask, N Shan, WDS Motherwell, W Jones, S Feng, RBH Tan, ... Chemical communications, 880-882, 2005 | 141 | 2005 |
| Screening for crystalline salts via mechanochemistry AV Trask, DA Haynes, WDS Motherwell, W Jones Chemical communications, 51-53, 2006 | 115 | 2006 |
| Guest-directed assembly of caffeine and succinic acid into topologically different heteromolecular host networks upon grinding T Friscic, AV Trask, WDS Motherwell, W Jones Crystal Growth and Design 8 (5), 1605-1609, 2008 | 111 | 2008 |
| Investigating the latent polymorphism of maleic acid GM Day, AV Trask, WDS Motherwell, W Jones Chemical communications, 54-56, 2006 | 77 | 2006 |
| Obvious to Try: A Proper Patentability Standard in the Pharmaceutical Arts AV Trask Fordham L. Rev. 76, 2625, 2007 | 33 | 2007 |
| Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production JC Kath, DT Richter, ZJ Li, AV Trask US Patent 6,844,349, 2005 | 28 | 2005 |
| Crystal forms of azithromycin ZJ Li, AV Trask US Patent 7,053,192, 2006 | 27 | 2006 |
| Crystal forms of azithromycin ZJ Li, AV Trask US Patent 6,977,243, 2005 | 18 | 2005 |
| Stable non-dihydrate azithromycin oral suspensions ZJ Li, AV Trask US Patent 6,861,413, 2005 | 16 | 2005 |
| Crystal forms of an imidazole derivative N Haruta, T Kato, ZJ Li, T Numata, AV Trask US Patent 7,960,407, 2011 | 14 | 2011 |
| Complexes of E-2-Methoxy-N (3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinzazolin-6-YL}-allyl)-acetamide, their method of production, and use Z Li, J Leonard, A Trask, J Kath, D Richter, C Thompson US Patent App. 10/738,972, 2005 | 13 | 2005 |
